J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M800130-JLR200 on March 26, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M800130-JLR200v1
49/7/1553    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Hu, L.
Right arrow Articles by Rensen, P. C. N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, L.
Right arrow Articles by Rensen, P. C. N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 49, 1553-1561, July 2008
Copyright © 2008 by American Society for Biochemistry and Molecular Biology

The hepatic uptake of VLDL in lrpldlr–/–vldlr–/– mice is regulated by LPL activity and involves proteoglycans and SR-BI

Lihui Hu1,*,{dagger}, Caroline C. van der Hoogt1,*,{dagger}, Sonia M. S. Espirito Santo*,{dagger}, Ruud Out§, Kyriakos E. Kypreos**, Bart J. M. van Vlijmen*,{dagger}, Theo J. C. Van Berkel§, Johannes A. Romijn{dagger}, Louis M. Havekes*,{dagger},{dagger}{dagger}, Ko Willems van Dijk{dagger},§§ and Patrick C. N. Rensen2,*,{dagger}

* Netherlands Organization for Applied Scientific Research-Quality of Life, Gaubius Laboratory, 2301 CE Leiden, The Netherlands
{dagger} Department of General Internal Medicine, Endocrinology and Metabolic Diseases, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
§ Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University, 2300 RA Leiden, The Netherlands
** Department of Medicine, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118
{dagger}{dagger} Department of Cardiology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
§§ Department of Human Genetics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands

This work was performed in the framework of the Leiden Center for Cardiovascular Research LUMC-TNO and was supported by the Leiden University Medical Center (Gisela Thier Fellowship to P.C.N.R.), the Netherlands Organization for Scientific Research (NWO Grant 908-02-097 and NWO VIDI Grant 917.36.351 to P.C.N.R.), and the Netherlands Heart Foundation (NHS Grant 2003B136 to P.C.N.R.).

Published, JLR Papers in Press, March 26, 2008.

1 These authors contributed equally to this study.

2 To whom correspondence should be addressed: e-mail: p.c.n.rensen{at}lumc.nl

LPL activity plays an important role in preceding the VLDL remnant clearance via the three major apolipoprotein E (apoE)-recognizing receptors: the LDL receptor (LDLr), LDL receptor-related protein (LRP), and VLDL receptor (VLDLr). The aim of this study was to determine whether LPL activity is also important for VLDL remnant clearance irrespective of these receptors and to determine the mechanisms involved in the hepatic remnant uptake. Administration of an adenovirus expressing LPL (AdLPL) into lrpldlr/vldlr/ mice reduced both VLDL-triglyceride (TG) and VLDL-total cholesterol (TC) levels. Conversely, inhibition of LPL by AdAPOC1 increased plasma VLDL-TG and VLDL-TC levels. Metabolic studies with radiolabeled VLDL-like emulsion particles showed that the clearance and hepatic association of their remnants positively correlated with LPL activity. This hepatic association was independent of the bridging function of LPL and HL, since heparin did not reduce the liver association. In vitro studies demonstrated that VLDL-like emulsion particles avidly bound to the cell surface of primary hepatocytes from lrpldlr/vldlr/ mice, followed by slow internalization, and involved heparin-releaseable cell surface proteins as well as scavenger receptor class B type I (SR-BI). Collectively, we conclude that hepatic VLDL remnant uptake in the absence of the three classical apoE-recognizing receptors is regulated by LPL activity and involves heparan sulfate proteoglycans and SR-BI.

Supplementary key words lipoprotein lipase • low density lipoprotein receptor • very low density lipoprotein receptor • low density lipoprotein receptor-related protein • triglyceride-rich emulsion particles • transgenic mice • adenovirus-mediated gene transfer • apolipoprotein E


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.